A detailed history of Syntax Research, Inc. transactions in Cvs Health Corp stock. As of the latest transaction made, Syntax Research, Inc. holds 772 shares of CVS stock, worth $34,678. This represents 0.03% of its overall portfolio holdings.

Number of Shares
772
Previous 927 16.72%
Holding current value
$34,678
Previous $54.7 Million 11.33%
% of portfolio
0.03%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 17, 2024

SELL
$55.81 - $63.18 $8,650 - $9,792
-155 Reduced 16.72%
772 $48.5 Million
Q4 2023

Jan 30, 2024

SELL
$66.29 - $79.0 $795 - $948
-12 Reduced 1.28%
927 $73.2 Million
Q3 2023

Nov 14, 2023

BUY
$65.17 - $76.41 $61,194 - $71,748
939 New
939 $65.6 Million

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $59B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Syntax Research, Inc. Portfolio

Follow Syntax Research, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Research, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Syntax Research, Inc. with notifications on news.